Hims & Hers Health (HIMS) reported Q4 earnings Monday of $0.11 per diluted share, up from $0.01 a year earlier.
Analysts polled by FactSet expected $0.11.
Revenue for the quarter ended Dec. 31 was $481.1 million, up from $246.6 million a year earlier.
Analysts surveyed by FactSet expected $470.3 million.
Gross margin was 77% for Q4, compared with 83% a year ago.
The company said it expects Q1 revenue to be between $520 million and $540 million. Analysts expected $497 million.
The company expects 2025 revenue of $2.3 billion to $2.4 billion. Analysts expected $2.09 billion.
The shares were falling past 17% in after-hours activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。